For sales

Highlights from the Week of 01st June – 08th June in the world of pharma and healthcare!

Highlights from the Week of 01st June 2026 - 08th June 2026 ( EU, Approval ) EC grants approval to Sanofi's SARCLISA SC in combination with standard-of-care regimens for the treatment of patients with multiple myeloma ( FDA, Orphan Drug, Fast Track ) TearSolutions' LACRIPEP received Orphan Drug and Fast Track designations from the FDA to treat neurotrophic keratitis ( FDA, Fast Track ) FDA grants Fast Track designation to Merakris Therapeutics' MTX-001 that treats venous leg ulcers ( FDA, Fast Track ) FDA provides Fast Track designation to Verastem Oncology's VS-7375 for the treatment of adult patients with KRAS G12D-mutated unresectable locally advanced or metastatic NSCLC Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.